NCT05273762View on ClinicalTrials.gov

Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

July 25, 2024

Conditions
Pulmonary Embolism
Interventions
DEVICE

FlowTriever

Mechanical thrombectomy for pulmonary embolism

Trial Locations (2)

10075

RECRUITING

Lenox Hill Hospital, New York

10549

ENROLLING_BY_INVITATION

Northern Westchester Hospital, Mount Kisco

Sponsors

Lead Sponsor

Northwell Health

Collaborators (1)

Inari Medical
All Listed Sponsors
collaborator

Inari Medical

INDUSTRY

lead

Northwell Health

OTHER

NCT05273762 - Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever | Biotech Hunter | Biotech Hunter